Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice

Human Psychopharmacology

Volumn 15, Issue 2, 2000, Pages 95-101

  Samini, Morteza ^a   Fakhrian, Rashin ^a   Mohagheghi, Massoud ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bromocriptine; Levodopa; Mice; Morphine withdrawal symptoms

Indexed keywords

8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; BROMOCRIPTINE; LEVODOPA; MORPHINE; NALOXONE; PRAZOSIN; SKF 85366; SULPIRIDE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMBING; CONTROLLED STUDY; DOSE RESPONSE; JUMPING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REARING; WITHDRAWAL SYNDROME;

EID: 0034033035     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(200003)15:2<95::AID-HUP148>3.0.CO;2-A     Document Type: Article

References (29)

1. Bhargava, H. N. (1980). Cyclo(leucyl glycine) inhibits the development of morphine-induced analgesic tolerance and dopamine receptor supersensitivity in rats. Life Science, 27, 117-123.
2. 2 and cyclo (Leu-Gly). Life Science, 29, 1945-1949.
3. 3H] SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. Journal of Pharmacology and Experimental Therapeutics, 252, 901-907.
4. Bongianni, F., Carlo, V., Moroni, F. and Pellegrini-Giampietro, D. E. (1986). Calcium channel inhibitors suppress the morphine withdrawal syndrome in rats. British Journal of Pharmacology, 88, 561-567.
5. El-Kadi, A. O. S. and Sharif, S. I. (1995). Investigation into the action of various adrenergic drugs in the expression of morphine withdrawal symptoms. Pharmaceutical and Pharmacological Letters, 3, 112-115.
6. El-Kadi, A. O. S. and Sharif, S. I. (1997). The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal. Psychopharmacology, 132, 67-73.
7. El-Kadi, A. O. S. and Sharif, S. I. (1998). The role of dopamine in the expression of morphine withdrawal. General Pharmacology, 30, 499-505.
8. Gibson, A. and Samini, M. (1978). Bromocriptine is a potent α-adrenoceptor antagonist in the perfused mesenteric blood vessels of the rat. Journal of Pharmacy and Pharmacology, 30, 314-315.
9. Gibson, A. and Samini, M. (1979). The effects of bromocriptine on pre-synaptic and post-synaptic α-adrenoceptors in the mouse vas deferens. Journal of Pharmacy and Pharmacology, 31, 826-830.
10. Gomaa, A. A., Mohamed, L. H. and Ahmed, H. N. (1989). Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. European Journal of Pharmacology, 170, 129-135.
11. Hamilton, T. C. (1981). Involvement of the adrenal glands in the hypotensive response to bromocriptine in spontaneously hypertensive rats. British Journal of Pharmacology, 72, 419-425.
12. Heijna, M. H., Padt, M., Hogenboom, F., Mulder, A. H. and Schoffelmeer, A. N. M. (1990). Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. European Journal of Pharmacology, 181, 267-278.
13. Ishikawa, K., Shibanoki, S. and McGaugh, J. L. (1983). Direct correlation between levels of morphiine and its biochemical effect on monoamine systems in mouse brain. Biochemical Pharmacology, 32, 1473-1478.
14. Iversen, S. D. and Joyce, E. M. (1978). Effect in the rat of chronic morphine treatment and behavioural response to apomorphine. British Journal of Pharmacology, 62, 390-391.
15. Johnson, A. M., Loew, D. M. and Vigouret, J. M. (1976). Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and 1-dopa. British Journal of Pharmacology, 56, 59-68.
16. Loh, H. H., Brase, D. A., Sampath-Khanna, S., Mar, J. B. and Way, E. L. (1976). β-endorphin in vitro inhibition of striatal dopamine release. Nature, 264, 567-568.
17. Marshall, I. and Grahame-Smith, D. G. (1971). Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice. Journal of Pharmacology and Experimental Therapeutics, 179, 634-641.
18. Martin, J. R. and Takemori, A. E. (1986). Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity. Journal of Pharmacology and Experimental Therapeutics, 241, 48-55.
19. Pollard, H., Lorens-Cortes, C. L. and Schwartz, J. C. (1977). Enkephalin receptors on dopaminergic neurones in rat striatum. Nature, 268, 745-747.
20. Puri, S. K. and Lal, H. (1973). Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression. Psychopharmacologia, 32, 113-120.
21. Redmond, D. E. and Krystal, J. H. (1984). Multiple mechanisms of withdrawal from opioid drugs. Annual Review of Neuroscience, 7, 443-478.
22. Ritzmann, R. F., Walter, R., Bhargava, H. N. and Flexner, L. B. (1979). Blockade of narcotic induced dopamine receptor supersensitivity by cyclo(Leu-Gly). Proceedings of the National Academy of Sciences of the USA, 76, 5997-5998.
23. Samini, M., Dehpour, A. R. and Yousefnejad, S. (1997). The effects of dopaminergic and adrenergic drugs on twitch response of guinea-pig common bile duct. General Pharmacology, 29, 469-471.
24. Sharif, S. I. and El-Kadi, A. O. S. (1996). Modification of naloxone-precipitated withdrawal symptoms in mice by drugs acting on α2-adrenoceptors. Behavioural Pharmacology, 7, 334-340.
25. Spampinato, U., Inveernizzi, R., Nowakowska, E. and Samanin, R. (1984). Reduction of morphine's effect on striatal dopamine metabolism in rats treated with a low dose of apomorphine of agents increasing serotonin transmission. Biochemical Pharmacology, 33, 163-170.
26. Thorner, M. O. (1975). Dopamine is an important neurotransmitter in the autonomic nervous system. The Lancet, March 22, 662-665.
27. Van Loon, G. R. (1978). Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF. Nature, 275, 331-332.
28. Walker, J. M., Thompson, L. A., Frascella, J. and Friederich, M. W. (1987). Opposite effects of μ and κ opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. European Journal of Pharmacology, 134, 53-59.
29. Werling, L. L., Frattali, A., Portoghese, P. S., Takemori, A. E. and Cox, B. M. (1988). Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. Journal of Pharmacology and Experimental Therapeutics, 246, 282-286.